Search research articles
Contact Us
Filters
Showing results (251-260 of 465) with videos related to
Page
of 47
Sort By:
Bioorganic & Medicinal Chemistry
|
November 23, 2013
Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [(11)C]IPCIT and [(18)F]FE@IPCIT
Christina Rami-Mark, Birgit Bornatowicz, Cornel Fink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 28, 2017
Glioma Survival Prediction with Combined Analysis of In Vivo <sup>11</sup>C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
László Papp, Nina Pötsch, Marko Grahovac, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2023
Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer
Bernhard Grubmüller, Nicolai A Huebner, Sazan Rasul, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 6, 2026
Lack of LAT1 and CD98hc Expression on Tumor Cells of Diffuse Glioma: Revisiting the Molecular Basis for Amino Acid PET Imaging and Theranostics
Jan-Michael Werner, Erwin Tomasich, Maximilian J Mair, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 17, 2025
Enhanced vascular inflammation in patients with advanced prostate cancer receiving hormone therapy
Holger Einspieler, Dina Muin, Ilva Kristiana Langrate, et al.
EJNMMI Research
|
August 7, 2012
Left ventricular functional assessment in murine models of ischemic and dilated cardiomyopathy using [18 F]FDG-PET: comparison with cardiac MRI and monitoring erythropoietin therapy
Stefan Brunner, Andrei Todica, Guido Böning, et al.
Urologic Oncology
|
February 22, 2024
Deep learning model for the detection of prostate cancer and classification of clinically significant disease using multiparametric MRI in comparison to PI-RADs score
Chunguang Yang, Basen Li, Yang Luan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 6, 2016
Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM)
Roberto Sciagrà, Alessandro Passeri, Jan Bucerius, et al.
EJNMMI Physics
|
November 3, 2024
Development of quantitative PET/MR imaging for measurements of hepatic portal vein input function: a phantom study
Zacharias Chalampalakis, Markus Ortner, Masar Almuttairi, et al.
European Urology Open Science
|
May 31, 2022
Feasibility and Optimal Time Point of [<sup>68</sup>Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of Surgery
Nicolai Huebner, Sazan Rasul, Pascal Baltzer, et al.
Page
of 47
Search research articles
Search
Showing results (251-260 of 465) with videos related to
Sort By:
Page
of 47
Bioorganic & Medicinal Chemistry
|
November 23, 2013
Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [(11)C]IPCIT and [(18)F]FE@IPCIT
Christina Rami-Mark, Birgit Bornatowicz, Cornel Fink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 28, 2017
Glioma Survival Prediction with Combined Analysis of In Vivo <sup>11</sup>C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
László Papp, Nina Pötsch, Marko Grahovac, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2023
Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer
Bernhard Grubmüller, Nicolai A Huebner, Sazan Rasul, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 6, 2026
Lack of LAT1 and CD98hc Expression on Tumor Cells of Diffuse Glioma: Revisiting the Molecular Basis for Amino Acid PET Imaging and Theranostics
Jan-Michael Werner, Erwin Tomasich, Maximilian J Mair, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 17, 2025
Enhanced vascular inflammation in patients with advanced prostate cancer receiving hormone therapy
Holger Einspieler, Dina Muin, Ilva Kristiana Langrate, et al.
EJNMMI Research
|
August 7, 2012
Left ventricular functional assessment in murine models of ischemic and dilated cardiomyopathy using [18 F]FDG-PET: comparison with cardiac MRI and monitoring erythropoietin therapy
Stefan Brunner, Andrei Todica, Guido Böning, et al.
Urologic Oncology
|
February 22, 2024
Deep learning model for the detection of prostate cancer and classification of clinically significant disease using multiparametric MRI in comparison to PI-RADs score
Chunguang Yang, Basen Li, Yang Luan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 6, 2016
Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM)
Roberto Sciagrà, Alessandro Passeri, Jan Bucerius, et al.
EJNMMI Physics
|
November 3, 2024
Development of quantitative PET/MR imaging for measurements of hepatic portal vein input function: a phantom study
Zacharias Chalampalakis, Markus Ortner, Masar Almuttairi, et al.
European Urology Open Science
|
May 31, 2022
Feasibility and Optimal Time Point of [<sup>68</sup>Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of Surgery
Nicolai Huebner, Sazan Rasul, Pascal Baltzer, et al.
Page
of 47